Cargando…

Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome—There is Meat on the Bone

Soluble ST2 (sST2) has recently emerged as a promising biomarker in the field of acute cardiovascular diseases. Several clinical studies have demonstrated a significant link between sST2 values and patients’ outcome. Further, it has been found that higher levels of sST2 are associated with an increa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aleksova, Aneta, Paldino, Alessia, Beltrami, Antonio Paolo, Padoan, Laura, Iacoviello, Massimo, Sinagra, Gianfranco, Emdin, Michele, Maisel, Alan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406787/ https://www.ncbi.nlm.nih.gov/pubmed/30813357 http://dx.doi.org/10.3390/jcm8020270

Ejemplares similares

Prognostic Value of sST2 in Heart Failure
por: Sciatti, Edoardo, et al.
Publicado: (2023)

sST2 association with atrial fibrillation development in patients with acute myocardial infarction with ST elevation
por: Rodionova, I, et al.
Publicado: (2023)

Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction
por: Gagno, Giulia, et al.
Publicado: (2019)

Biomarkers in the management of acute heart failure: state of the art and role in COVID‐19 era
por: Aleksova, Aneta, et al.
Publicado: (2021)

Assessment of sST2 Behaviors to Evaluate Severity/Clinical Impact of Acute Pulmonary Embolism
por: Petramala, Luigi, et al.
Publicado: (2023)

A meta-analysis of soluble suppression of tumorigenicity 2 (sST2) and clinical outcomes in pulmonary hypertension
por: Luk, King Sum, et al.
Publicado: (2017)

The IL-33/sST2 Axis in Thromboangiitis Obliterans
por: Sharebiani, Hiva, et al.
Publicado: (2020)

Sex and age differences in sST2 in cardiovascular disease
por: Beetler, Danielle J., et al.
Publicado: (2023)

sST2 and Heart Failure—Clinical Utility and Prognosis
por: Dudek, Magdalena, et al.
Publicado: (2023)

The Role of Exercise-Induced Molecular Processes and Vitamin D in Improving Cardiorespiratory Fitness and Cardiac Rehabilitation in Patients With Heart Failure
por: Aleksova, Aneta, et al.
Publicado: (2022)

Old and Novel Therapeutic Approaches in the Management of Hyperglycemia, an Important Risk Factor for Atherosclerosis
por: Janjusevic, Milijana, et al.
Publicado: (2022)

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure
por: Villacorta, Humberto, et al.
Publicado: (2016)

Reference interval and the role of soluble suppression of tumorigenicity 2 (sST2) in subclinical cardiac dysfunction at health checkups
por: Nah, Eun‐Hee, et al.
Publicado: (2020)

Could sST2 Predict Contrast-Induced Nephropathy in ST-Segment Elevation Myocardial Infarction?
por: Avcı, Ahmet, et al.
Publicado: (2020)

The Association of Serum IL-33 and sST2 with Breast Cancer
por: Yang, Zhi-Ping, et al.
Publicado: (2015)

Serum sST2 levels predict severe exacerbation of asthma
por: Watanabe, Masato, et al.
Publicado: (2018)

A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT)
por: Li, Junpei, et al.
Publicado: (2021)

Prognostic value of interleukin-33, sST2, myeloperoxidase, and matrix metalloproteinase-9 in acute aortic dissection
por: Jia, Yu, et al.
Publicado: (2023)

Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19
por: Arnaldos-Carrillo, María, et al.
Publicado: (2023)

Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
por: Akimoto, Miho, et al.
Publicado: (2016)

Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality
por: Aleksova, Aneta, et al.
Publicado: (2022)

Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction
por: Cui, Yameng, et al.
Publicado: (2018)

Predictive Value of GDF-15 and sST2 for Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Lv, Zhigan, et al.
Publicado: (2023)

Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review
por: Aleksova, Aneta, et al.
Publicado: (2021)

Correlation between Serum LP-PLA2 and sST2 Levels and the Condition of Patients with Acute Heart Failure and Their Prognostic Value
por: Zhu, Junguo, et al.
Publicado: (2021)

Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus
por: Li, Man, et al.
Publicado: (2021)

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
por: Stojkovic, Stefan, et al.
Publicado: (2020)

Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
por: Hong, Yeon-Sik, et al.
Publicado: (2011)

Increased levels of sST2 in patients with mitral annulus disjunction and ventricular arrhythmias
por: Scheirlynck, Esther, et al.
Publicado: (2019)

Non-cardiac Conditions Which Can Elevate The Serum Levels of sST2
por: Patil, T.R., et al.
Publicado: (2019)

Short-Term Prognosis Value of sST2 for an Unfavorable Outcome in Hypertensive Patients
por: Farcaş, Anca Daniela, et al.
Publicado: (2020)

Diabetes Mellitus and Vitamin D Deficiency: Comparable Effect on Survival and a Deadly Association after a Myocardial Infarction
por: Aleksova, Aneta, et al.
Publicado: (2020)

Retracted: Correlation between Serum LP-PLA2 and sST2 Levels and the Condition of Patients with Acute Heart Failure and Their Prognostic Value
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis
por: Ip, Christina, et al.
Publicado: (2021)

Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT‐HF study
por: Borovac, Josip A., et al.
Publicado: (2020)

Prognostic Role of sST2 in Acute Heart Failure and COVID-19 Infection—A Narrative Review on Pathophysiology and Clinical Prospective
por: Marino, Luca, et al.
Publicado: (2022)

Biomarkers of IL-33 and sST2 and Lack of Association with Carvedilol Therapy in Heart Failure
por: Firouzabadi, Negar, et al.
Publicado: (2020)

STADE‐HF (sST2 As a help for management of HF): a pilot study
por: Huet, Fabien, et al.
Publicado: (2020)

Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Zhang, Tianyi, et al.
Publicado: (2021)

Alteration of the IL-33-sST2 pathway in hypertensive patients and a mouse model
por: Yin, Xiaoyun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h1ifs7q1qujo9kqe8ifuehiv5l